ArticleJournal of cancer research and clinical oncology2013

L-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients' survival with stomach adenocarcinomas.

Dimitra Florou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.